Saturday, May 31, 2025

Latest

Haywood Reiterates $80 Price Target On Trulieve After Harvest Health Purchase

On October 1st, Trulieve Cannabis (CSE: TRUL) announced that they completed their $1.75 billion acquisition of Harvest Health. Harvest shareholders received 0.1170 shares of Trulieve for each subordinate voting share held.

A number of analysts raised their 12-month price targets off the back of the acquisition. This brought the average 12-month price target up to C$84.80, or a 137% upside. There are 17 analysts covering the stock, with 5 analysts having strong buy ratings and the other 12 have buy ratings. The street high sits at C$132 from Stifel-GMP while the lowest comes in at C$54.

In Haywood Capital Market’s note, they reiterated their C$80 price target and buy rating on Trulieve Cannabis saying that this establishes Trulieve as one of the top tier-1 MSO’s. They add, “The acquisition was completed within 5 months which is an impressive accomplishment in our view.”

With this acquisition, Trulieve grows its addressable market from 6 to 11, gaining 5 new markets and going deeper in 4 markets Haywood says. They believe that margin compression will come with the acquisition but comment that the additional markets are a worthy trade-off “for its long-term growth trajectory while also being able to maintain healthy margins.”

Below you can see Haywood’s updated 2021 and 2022 estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Alamos Gold Q1 Earnings: The Inside Scoop

Cerrado Gold Q4 Earnings: The Turnaround is Working

B2GOLD Q1 Earnings: Revenue Up, Production & Cash Flow Decline

Recommended

Canadian Copper: The $172M Combined Strategy PEA

ESGold Begins Concentration Tests Ahead Of First Production

Related News

Haywood Initiates Coverage On Ascend Wellness With $16.50 Price Target

Haywood Capital Markets recently became the latest firm to initiate coverage on Ascend Wellness (CSE:...

Wednesday, September 1, 2021, 03:33:00 PM

SSR Mining: Canaccord Reiterates Firm As Being A Top Pick

On August 4, SSR Mining (TSX: SSRM) reported its second quarter financial results. The company...

Monday, August 16, 2021, 11:34:00 AM

Tilray Sees Jefferies Lower Target Due To Canadian Cannabis Headwinds

Jefferies lowered their price target on Tilray Brands (TSX: TLRY), after updating their outlook, saying...

Sunday, April 10, 2022, 01:03:00 PM

Cineplex: Canaccord Pegs Chance Of $1.24 Billion In Damages Being Collected At 25%

On December 15th, Cineplex Inc. (TSX: CGX) was awarded roughly $1.24 billion in damages from...

Sunday, December 19, 2021, 03:17:00 PM

Topaz Energy: Canaccord Boosts Price Target To $19.00

Last week, Topaz Energy Corp. (TSX: TPZ) had a series of positive developments. First, the...

Monday, June 14, 2021, 11:46:00 AM